Log In
Print this Print this

Breo Ellipta, Relvar, Relvar Ellipta, fluticasone furoate/vilanterol (Relvar/Breo) (GW685698/GW64244) (formerly Relovair)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionFixed-dose combination of an inhaled corticosteroid and a long-acting adrenergic receptor beta 2 agonist (LABA) administered with the dry powder Ellipta inhaler
Molecular Target Adrenergic receptor beta 2 (ADRB2) ; Glucocorticoid receptor (GCCR)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today